Porphyria cutanea tarda: pathogenesis in relation to therapy
- PMID: 1935223
- DOI: 10.1159/000420012
Porphyria cutanea tarda: pathogenesis in relation to therapy
Similar articles
-
Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases.Clin Biochem. 1986 Feb;19(1):3-15. doi: 10.1016/s0009-9120(86)80064-9. Clin Biochem. 1986. PMID: 3513989 Review.
-
Hepatoerythropoietic porphyria: a new uroporphyrinogen decarboxylase defect or homozygous porphyria cutanea tarda?Lancet. 1981 Apr 25;1(8226):916-9. doi: 10.1016/s0140-6736(81)91615-9. Lancet. 1981. PMID: 6112327
-
[The porphyria cutanea tarda group: their role among the enzyme defects of heme biosynthesis].Sem Hop. 1984 Apr 12;60(16):1148-52. Sem Hop. 1984. PMID: 6326308 French.
-
[Porphyria cutanea tarda].Ann Dermatol Venereol. 1987;114(8):1023-6. Ann Dermatol Venereol. 1987. PMID: 3426071 French. No abstract available.
-
Porphyria cutanea tarda and bullous dermatoses associated with chronic renal failure: a review.Cleve Clin Q. 1983 Summer;50(2):151-61. doi: 10.3949/ccjm.50.2.151. Cleve Clin Q. 1983. PMID: 6357544 Review. No abstract available.
Cited by
-
[Pansclerotic porphyria cutanea tarda after chronic exposure to organic solvents].Hautarzt. 2003 May;54(5):448-52. doi: 10.1007/s00105-002-0448-3. Epub 2003 Feb 22. Hautarzt. 2003. PMID: 12719865 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical